But outside experts point to significant limitations of the research and say the findings should not be seen as definitive.
Jaw-dropping patient videos and miraculous testimonials ignited a frenzy in China over a technique that aims to improve ...
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time ...
The FDA approved Roche Diagnostics and Eli Lilly’s blood test to help doctors assess Alzheimer’s disease in people 55 and ...
Dr. Ian Grant, behavioral neurologist at Northwestern Medicine’s Cognitive Neurology & Alzheimer’s Disease Center, joins Bob ...
The next episode in this series, 'Empowering Primary Care: Early Alzheimer's Detection and the Referral Pathway Challenge,' features the panelists advancing their conversation on Alzheimer's disease ...
The adult human brain has limited capacity to repair or regenerate neurons lost to Alzheimer's disease, the most common type ...
What if amyloid plaques are not the whole story of Alzheimer's disease? New research suggests that a broad range of Alzheimer ...
What if amyloid plaques are not the whole story of Alzheimer's disease? New research suggests that a broad range of Alzheimer ...
Two University of Wyoming faculty members will further their research in understanding the microcircuit changes that occur in ...
Eli Lilly has secured another important foothold in Alzheimer's disease after the FDA approved a new blood test developed with Roche that ...
In this episode titled, 'Alzheimer's Disease Prevalence and Prevention: Building the Case for Early Diagnosis,' Kavita Nair, PhD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results